Among ERBB2-amplification patients, except for TP53 which was the top most mutated gene, PIK3CA ranked second of high frequency mutated genes in breast cancer (Figure 3A) and mutation of PREX2 was recurrent in stomach cancer (Figure 3B). This evidence concerns the gene PREX2 and breast carcinoma.